Objectif
In vitro diagnostics have allowed a great deal of progress in medicine but are limited by two factors: (a) the lack of guidelines in collection, handling, stabilisation and storage of biosamples which limits the reproducibility of subsequent diagnoses, and (b) its scale is restrained to the cellular level. To address this first point, this IP, SPIDIA, built of clinicians, academics, tool and assay developers, aims to develop quality guidelines for molecular in vitro diagnostics and to standardize the pre-analytical workflow in related procedures. Regarding the second point, SPIDIA aims to develop modern pre-analytical tools for diagnostics improving the stabilisation, handling and study of free biomolecules within blood, plasma, serum, tissues and tumours. Recent discoveries have revealed that RNA, DNA or proteins, released from pathological sites, like tumour cells or Alzheimer’s disease (AD) brain lesions, into the blood or as a secondary blood based response to the disease can serve as biomarkers for early and reliable molecular diagnosis of such debilitating diseases. Further discoveries have shown that the cellular profiles of these molecules and structures in clinical samples can change during transport and storage thus making clinical assay results and pharmaceutical research unreliable or even impossible. It will therefore be a decisive prerequisite for future and current diagnostic assays to develop standards and new technologies, tools and devices that eliminate the human error in the pre-analytical steps of in vitro diagnostics. At this crucial moment in the development of molecular diagnostics, SPIDIA proposes an IP that reunites 7 private research companies (including 4 SMEs), 1 private research institute, 6 public research organisms, including universities, hospitals and biobanks, one management SME and an official European Standards Organisation. This strong consortium is balanced and empowered to maximise the impacts of in vitro diagnostics on human health.
Champ scientifique
Mots‑clés
Appel à propositions
FP7-HEALTH-2007-B
Voir d’autres projets de cet appel
Régime de financement
CP-IP - Large-scale integrating projectCoordinateur
40724 Hilden
Allemagne
Voir sur la carte
Participants (16)
8010 Graz
Voir sur la carte
50121 FIRENZE
Voir sur la carte
412 51 GOTEBORG
Voir sur la carte
8634 HOMBRECHTIKON
Voir sur la carte
0663 OSLO
Voir sur la carte
8200 AARHUS
Voir sur la carte
2600 GLOSTRUP
Voir sur la carte
Participation terminée
69002 LYON
Voir sur la carte
252 50 Vestec
Voir sur la carte
1040 Bruxelles / Brussel
Voir sur la carte
38100 GRENOBLE
Voir sur la carte
50121 Florence
Voir sur la carte
3015 GD Rotterdam
Voir sur la carte
80333 Muenchen
Voir sur la carte
20133 Milan
Voir sur la carte
69002 LYON
Voir sur la carte